Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Registration for Controlled Substances Act Data-Use Request, 94763-94764 [2024-28045]
Download as PDF
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 22, 2024, Curia
Wisconsin, Inc., 870 Badger Circle,
Grafton, Wisconsin 53024–9436,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Controlled substance
Gamma Hydroxybutyric Acid.
Marihuana Extract ....
Marihuana .................
Dimethyltryptamine ...
Drug
code
Schedule
2010
I
7350
7360
7435
I
I
I
The company plans to import the
listed controlled substances for
analytical testing or distribution. No
other activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–28063 Filed 11–27–24; 8:45 am]
BILLING CODE P
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 30, 2024. Such
persons may also file a written request
for a hearing on the application on or
before December 30, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 18, 2024, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
DATES:
DEPARTMENT OF JUSTICE
Controlled substance
Drug Enforcement Administration
Psilocybin ........................
4-Anilino-N-phenethyl-4piperidine (ANPP).
Phenylacetone .................
Coca Leaves ...................
Opium Raw ......................
Poppy Straw Concentrate
[Docket No. DEA–1460]
Importer of Controlled Substances
Application: Cambrex Charles City
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
khammond on DSK9W7S144PROD with NOTICES
AGENCY:
Cambrex Charles City has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
SUMMARY:
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
Drug
code
Schedule
7437
8333
I
II
8501
9040
9600
9670
II
II
II
II
The company plans to import
psilocybin for formulation development
and clinical trial support for their
customers. The remaining listed
controlled substances will be imported
to support the manufacture into other
controlled substances which will be
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
94763
distributed to their customers. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–28064 Filed 11–27–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0059]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Previously Approved Collection;
Registration for Controlled Substances
Act Data-Use Request
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 30, 2024.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Heather E. Achbach, Regulatory
Drafting and Policy Support Section,
Drug Enforcement Administration;
Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152;
Telephone: (571) 776–3882; Email:
DEA.PRA@dea.gov or
Heather.E.Achbach@dea.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on September 24, 2024, at 89
FR 77895, allowing for a 60-day
comment period. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
SUMMARY:
E:\FR\FM\29NON1.SGM
29NON1
94764
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
khammond on DSK9W7S144PROD with NOTICES
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 1117–0059. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB.
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOJ notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Overview of This Information
Collection:
1. Type of Information Collection:
Extension of a previously approved
collection.
2. Title of the Form/Collection:
Registration for CSA Data-Use Request.
3. Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: No form number is
associated with this collection. The
applicable component within the
Department of Justice is the Drug
Enforcement Administration, Diversion
Control Division.
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, Local, and
tribal governments.
5. Abstract: In accordance with the
Controlled Substance Act (CSA), every
person who manufactures, distributes,
dispenses, conducts research with,
imports, or exports any controlled
substance to obtain a registration issued
by the Attorney General. 21 U.S.C. 822,
823, and 957. While DEA registrants are
able to self-verify their registration
status, non-registrants do not have an
obligation to register under the CSA,
and therefore does not have an
automatic means to verify the
registration of a DEA-registrant. Nonregistrants have obligations to verify the
registration statuses before doing things
such as hiring practitioners, paying for
controlled substance prescriptions
covered by Medicaid or Medicare, and
other means that are apart of commerce.
This proposed collection would allow
non-registrants to register for access to
the CSA Database System, which gives
the names and registration statuses of all
DEA-registrants. Applicants would be
required to re-apply annually by
completing this form and submitting to
DEA.
6. Obligation to Respond: Required to
obtain or retain benefits.
7. Total Estimated Number of
Respondents: 9,000.
8. Estimated Time per Respondent: 15
minutes.
9. Frequency: 1 per year.
10. Total Estimated Annual Time
Burden: 2,250 hours.
11. Total Estimated Annual Other
Costs Burden: $0.
If additional information is required,
contact: Darwin Arceo, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
United States Department of Justice,
Two Constitution Square, 145 N Street
NE, 4W–218 Washington, DC 20530.
Dated: November 25, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2024–28045 Filed 11–27–24; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[OMB Number 1125–0010]
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested; Extension of a
Previously Approved Collection;
Notice of Appeal to the Board of
Immigration Appeals From a Decision
of a DHS Officer (EOIR–29)
Executive Office for
Immigration Review, Department of
Justice.
ACTION: 30-Day notice.
AGENCY:
The Executive Office for
Immigration Review (EOIR), Department
of Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 30, 2024.
FOR FURTHER INFORMATION CONTACT: The
proposed information collection was
previously published in the Federal
Register on September 13, 2024, 89 FR
76510, allowing a 60 day-comment
period. If you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Zach Leciejewski, Attorney Advisor,
Executive Office for Immigration
Review, 5107 Leesburg Pike, Suite 2500,
Falls Church, VA 22041, phone (703)
305–0990 or email eoir.pra.comments@
usdoj.gov or Zach.Leciejewski@
usdoj.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
SUMMARY:
E:\FR\FM\29NON1.SGM
29NON1
Agencies
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94763-94764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28045]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0059]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Extension of a Previously Approved Collection;
Registration for Controlled Substances Act Data-Use Request
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 30 days until
December 30, 2024.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact Heather E.
Achbach, Regulatory Drafting and Policy Support Section, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
[email protected] or [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on September 24, 2024, at
89 FR 77895, allowing for a 60-day comment period. Written comments and
suggestions from the public and affected agencies concerning the
proposed collection of information are encouraged. Your comments should
[[Page 94764]]
address one or more of the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website www.reginfo.gov/public/do/PRAMain.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 1117-0059. This information collection request
may be viewed at www.reginfo.gov. Follow the instructions to view
Department of Justice, information collections currently under review
by OMB.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Overview of This Information Collection:
1. Type of Information Collection: Extension of a previously
approved collection.
2. Title of the Form/Collection: Registration for CSA Data-Use
Request.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: No form number is
associated with this collection. The applicable component within the
Department of Justice is the Drug Enforcement Administration, Diversion
Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, Local, and tribal governments.
5. Abstract: In accordance with the Controlled Substance Act (CSA),
every person who manufactures, distributes, dispenses, conducts
research with, imports, or exports any controlled substance to obtain a
registration issued by the Attorney General. 21 U.S.C. 822, 823, and
957. While DEA registrants are able to self-verify their registration
status, non-registrants do not have an obligation to register under the
CSA, and therefore does not have an automatic means to verify the
registration of a DEA-registrant. Non-registrants have obligations to
verify the registration statuses before doing things such as hiring
practitioners, paying for controlled substance prescriptions covered by
Medicaid or Medicare, and other means that are apart of commerce. This
proposed collection would allow non-registrants to register for access
to the CSA Database System, which gives the names and registration
statuses of all DEA-registrants. Applicants would be required to re-
apply annually by completing this form and submitting to DEA.
6. Obligation to Respond: Required to obtain or retain benefits.
7. Total Estimated Number of Respondents: 9,000.
8. Estimated Time per Respondent: 15 minutes.
9. Frequency: 1 per year.
10. Total Estimated Annual Time Burden: 2,250 hours.
11. Total Estimated Annual Other Costs Burden: $0.
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.
Dated: November 25, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-28045 Filed 11-27-24; 8:45 am]
BILLING CODE 4410-09-P